Human papillomavirus: science and technologies for the elimination of cervical cancer

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1999 • 8,737 citations

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

2003 • 6,072 citations

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

1995 • 3,371 citations

A review of human carcinogens—Part B: biological agents

2009 • 2,713 citations

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

2010 • 2,440 citations

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

2007 • 1,829 citations

Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update

2007 • 1,654 citations

Centers for Disease Control and Prevention (CDC) : Advisory Committee on Immunization Practices (ACIP) : Quadrivalent human papillomavirus vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)

2007 • 1,644 citations

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

2003 • 1,535 citations

Chapter 1: HPV in the etiology of human cancer

2006 • 1,344 citations

HPV Screening for Cervical Cancer in Rural India

2009 • 1,199 citations

Against which human papillomavirus types shall we vaccinate and screen? the international perspective

2004 • 1,099 citations

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

2006 • 1,084 citations

The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice

2005 • 1,038 citations

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

2010 • 884 citations

Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

2008 • 817 citations

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

2007 • 786 citations

The cervical cancer epidemic that screening has prevented in the UK

2004 • 772 citations

Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention

2006 • 656 citations

Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries

2008 • 637 citations

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

2007 • 630 citations

Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses

2006 • 538 citations

A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China

2008 • 473 citations

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

2002 • 423 citations

Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries

2005 • 374 citations

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

2008 • 334 citations

A critical assessment of screening methods for cervical neoplasia

2005 • 303 citations

Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial

2006 • 303 citations

Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States

2009 • 244 citations

Social and psychological impact of HPV testing in cervical screening: a qualitative study

2006 • 237 citations

Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination

2006 • 235 citations

Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears

2008 • 232 citations

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women

2009 • 223 citations

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

2009 • 165 citations

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid‐based cytology in primary cervical cancer screening: The FASE study

2010 • 146 citations

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996

2004 • 137 citations

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

2008 • 136 citations

Training for cervical cancer prevention programs in low‐resource settings: Focus on visual inspection with acetic acid and cryotherapy

2005 • 128 citations

New Technologies in Cervical Cancer Screening

2008 • 122 citations

Modeling Cervical Cancer Prevention in Developed Countries

2008 • 117 citations

Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

2009 • 112 citations

Human Papillomavirus Infection and Cervical Cancer Prevention in India, Bangladesh, Sri Lanka and Nepal

2008 • 103 citations

HPV and cervical cancer: screening or vaccination?

2008 • 91 citations

Results of the First World Health Organization International Collaborative Study of Detection of Human Papillomavirus DNA

2006 • 76 citations

Prevalence of Human Papillomavirus Types in High-Grade Cervical Intraepithelial Neoplasia and Cancer in Italy

2010 • 70 citations

Immunobiology of Human Papillomavirus Infection and Vaccination - Implications for Second Generation Vaccines

2008 • 68 citations

Analytical characterization of the APTIMA® HPV Assay

2009 • 68 citations

Disease eradication as a public health strategy: a case study of poliomyelitis eradication.

2000 • 62 citations

Mathematical Models of Cervical Cancer Prevention in Latin America and the Caribbean

2008 • 58 citations

Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement

2008 • 54 citations

The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment

2007 • 19 citations

Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate

2006 • 16 citations

Evaluating the potential benefits of universal worldwide human papillomavirus vaccination

2008 • 7 citations

Implementation of prophylactic HPV vaccination: progress and future challenges

2010 • 4 citations

Deleted Work

1955 • 0 citations